Meglumine Gadoterate: A New Safe Radiocontrast Medium for Endoscopic Retrograde Cholangiopancreatography?
| Autor: | A. Uske, Gian Dorta, A.L. Blum |
|---|---|
| Rok vydání: | 1997 |
| Předmět: |
Adult
Male medicine.medical_specialty Pancreatic disease Adolescent Contrast Media Gadolinium Gallstones Meglumine Organometallic Compounds medicine Humans In patient Biliary Tract Aged Aged 80 and over Cholangiopancreatography Endoscopic Retrograde Endoscopic retrograde cholangiopancreatography medicine.diagnostic_test Gadoteridol business.industry Bile duct Pancreatic Ducts Gastroenterology Magnetic resonance imaging Middle Aged medicine.disease Iothalamic Acid Endoscopy Radiographic Image Enhancement medicine.anatomical_structure Pancreatitis Female Radiology business medicine.drug |
| Zdroj: | Digestion. 58:289-292 |
| ISSN: | 1421-9867 0012-2823 |
| Popis: | The radiocontrast substance meglumine gadoterate (MG) is used in magnetic resonance imaging. It is characterized by its low rate of adverse drug reactions. In an open study we tested whether MG is useful in endoscopic retrograde cholangiopancreatography. The patients received in sequence MG and ioxotalamate. MG, in contrast to ioxotalamate, failed to visualize the proximal pancreatic and peripheral intrahepatic ducts. Thus, MG is not useful in routine endoscopic retrograde cholangiopancreatography. However, in patients with a history of severe allergic reactions to conventional contrast media, MG may be recommended when pathological findings of the extrahepatic bile duct or the area of the pancreatic head are suspected. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|